当前位置:首页 - 行情中心 - 药易购(300937) - 财务分析 - 资产负债表

药易购

(300937)

  

流通市值:14.97亿  总市值:22.86亿
流通股本:6264.79万   总股本:9566.67万

资产负债表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
流动资产:
货币资金378,472,730.05374,864,119.57251,736,712.23161,536,307.3
结算备付金-0--
拆出资金-0--
衍生金融资产-0--
应收票据及应收账款464,574,110.3123,134,181.47431,673,388.26396,386,733.2
其中:应收票据6,650,00004,045,744.25475,000
应收账款457,924,110.3123,134,181.47427,627,644.01395,911,733.2
应收款项融资23,258,973.4773,410,161.2716,777,736.314,653,591.48
预付款项132,511,360.1163,561,999.03102,125,850.11104,786,214.51
应收保费-0--
应收分保账款-0--
应收分保合同准备金-0--
其他应收款合计65,421,013.3960,734,594.915,639,092.8911,625,329.55
其中:应收利息783,321.65---
存货516,841,959.2561,237,355.76452,606,615.63464,161,799.19
合同资产-0--
一年内到期的非流动资产4,873,903.581,870,736.53,925,0002,000,000
其他流动资产35,298,267.613,629,477.2813,234,092.4614,678,762.05
流动资产平衡项目0000
流动资产合计1,625,252,317.691,376,442,625.781,291,316,222.471,174,026,471.87
非流动资产:
发放委托贷款及垫款-0--
债权投资7,301,205.2211,808,704.99--
其他债权投资-09,820,00012,970,000
长期应收款2,108,6962,108,69648,728,69647,500,000
长期股权投资16,371,914.1910,829,001.794,812,213.115,583,670.71
其他权益工具投资6,314,853.845,613,849.135,588,849.134,538,888.88
其他非流动金融资产-0--
投资性房地产-0--
固定资产141,531,353.32142,203,630.71143,804,987.53152,066,123
在建工程6,063,976.472,205,713.341,627,433.631,706,930.24
使用权资产8,702,263.279,640,299.037,173,036.58,505,914.56
无形资产45,423,955.9546,432,202.447,628,990.1548,849,684.53
开发支出23,561,116.3523,542,131.9417,861,311.1812,698,759.74
商誉16,468,131.7616,468,131.7616,468,131.7616,356,856.47
长期待摊费用20,406,989.9120,373,831.2321,207,497.220,995,417.52
递延所得税资产18,923,514.2415,231,934.369,224,270.319,474,813.48
其他非流动资产-4,164,47525,000238,200
非流动资产平衡项目0000
非流动资产合计313,177,970.52310,622,601.68333,970,416.5341,485,259.13
资产平衡项目0000
资产总计1,938,430,288.211,687,065,227.461,625,286,638.971,515,511,731
流动负债:
短期借款408,706,533.89320,738,176.85193,187,180.56125,115,763.89
向中央银行借款-0--
吸收存款及同业存放-0--
拆入资金-0--
交易性金融负债-0--
衍生金融负债-0--
应付票据及应付账款509,398,171.55359,664,472.83460,311,544.66416,644,085.17
其中:应付票据152,525,651.54148,171,166.2874,819,090.15120,444,418.98
应付账款356,872,520.01211,493,306.55385,492,454.51296,199,666.19
预收款项-00-
合同负债49,766,07553,570,400.5444,492,031.4143,814,375
卖出回购金融资产款-0--
应付手续费及佣金-0--
应付职工薪酬11,477,366.8718,945,396.5612,927,482.6113,277,910.48
应交税费10,734,602.629,607,386.885,253,245.168,172,097.38
其他应付款合计10,601,034.1111,216,530.198,648,113.2710,351,283.32
应付分保账款-0--
保险合同准备金-0--
代理买卖证券款-0--
代理承销证券款-0--
一年内到期的非流动负债10,489,322.7212,979,948.673,852,955.529,241,802.69
其他流动负债34,253,945.3314,402,185.7216,673,399.6413,562,503.01
流动负债平衡项目0000
流动负债合计1,045,427,052.09801,124,498.24745,345,952.83640,179,820.94
非流动负债:
长期借款-0--
应付债券-0--
优先股-0--
永续债-0--
租赁负债4,858,951.784,685,059.272,188,477.272,390,408.29
长期应付款7,240,395.76,875,631.1714,143,396.249,886,792.46
长期应付职工薪酬-0--
预计负债-0-80,000
递延收益4,919,426.465,000,423.895,081,712.655,162,592.03
递延所得税负债12,720,219.3513,337,855.239,132,653.329,445,087.11
其他非流动负债-0--
非流动负债平衡项目0000
非流动负债合计29,738,993.2929,898,969.5630,546,239.4826,964,879.89
负债平衡项目0000
负债合计1,075,166,045.38831,023,467.8775,892,192.31667,144,700.83
所有者权益(或股东权益):
实收资本(或股本)95,666,68295,666,68295,666,68295,666,682
其他权益工具-0--
优先股-0--
永续债-0--
资本公积474,005,460.03474,005,460.03474,040,244.01474,040,244.01
减:库存股-0--
其他综合收益-0--
专项储备-0--
盈余公积39,145,368.7239,145,368.7232,980,891.9933,295,891.99
一般风险准备-0--
未分配利润254,628,445.58245,402,914.27242,192,633.3241,588,032.61
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计863,445,956.33854,220,425.02844,880,451.3844,590,850.61
少数股东权益-181,713.51,821,334.644,513,995.363,776,179.56
股东权益平衡项目0000
股东权益合计863,264,242.83856,041,759.66849,394,446.66848,367,030.17
负债和股东权益合计1,938,430,288.211,687,065,227.461,625,286,638.971,515,511,731
公告日期2024-04-252024-04-102023-10-282023-08-23
审计意见(境内)标准无保留意见
TOP↑